Advances in medical treatment for pancreatic neuroendocrine neoplasms

por Li, Yuan-Liang, Cheng, Zi-Xuan, Yu, Fu-Huan, Tian, Chao, Tan, Huang-Ying
Publicado 2022

Circulating miRNA-202-3p is a potential novel biomarker for diagnosis of type 1 gastric neuroendocrine neoplasms

por Dou, Dou, Li, Xiao-kou, Xia, Qi-sheng, Chen, Ying-ying, Li, Yuan-liang, Wang, Chao, Qi, Zhi-rong, Tan, Huang-ying
Publicado 2021

Clinicopathological characteristics and risk factors for recurrence of well-differentiated pancreatic neuroendocrine tumors after radical surgery: a case-control study

por Zhang, Pan, Li, Yuan-liang, Qiu, Xu-dong, Luo, Jie, Shi, Yan-fen, Sun, Yong-liang, Su, Fei, Qi, Zhi-rong, Tan, Huang-ying
Publicado 2019

Clinicopathological characteristics and prognosis of 77 cases with type 3 gastric neuroendocrine tumours

por Li, Yuan-Liang, Qiu, Xu-Dong, Chen, Jie, Zhang, Yu, Li, Jie, Xu, Jian-Ming, Wang, Chao, Qi, Zhi-Rong, Luo, Jie, Tan, Huang-Ying
Publicado 2020

Hsa-miR-202-3p, up-regulated in type 1 gastric neuroendocrine neoplasms, may target DUSP1

por Dou, Dou, Shi, Yan-Fen, Liu, Qing, Luo, Jie, Liu, Ji-Xi, Liu, Meng, Liu, Ying-Ying, Li, Yuan-Liang, Qiu, Xu-Dong, Tan, Huang-Ying
Publicado 2018

Clinicopathological characteristics and prognosis of 232 patients with poorly differentiated gastric neuroendocrine neoplasms

por Han, Deng, Li, Yuan-Liang, Zhou, Zhi-Wei, Yin, Fei, Chen, Jie, Liu, Fang, Shi, Yan-Fen, Wang, Wei, Zhang, Yu, Yu, Xian-Jun, Xu, Jian-Ming, Yang, Run-Xiang, Tian, Chao, Luo, Jie, Tan, Huang-Ying
Publicado 2021